using glioblastoma cell lines T98G (P53-mutant) and A172 (P53-wild type) to investigate the relationship between P53 mutations and sensitivity in combination with the DNA-alkylating agent temozolomide (TMZ) and neutron radiation (54). Here, TP53 is linked to glioblastoma.